[HTML][HTML] CDK inhibitors in cancer therapy, an overview of recent development
M Zhang, L Zhang, R Hei, X Li, H Cai… - American journal of …, 2021 - ncbi.nlm.nih.gov
Dysregulated cell division, which leads to aberrant cell proliferation, is one of the key
hallmarks of cancer. Therefore, therapeutic targets that block cell division would be effective …
hallmarks of cancer. Therefore, therapeutic targets that block cell division would be effective …
Chemistry and biology of multicomponent reactions
Multicomponent reactions (MCRs) are one-pot reactions employing more than two starting
materials, for example, 3, 4,..., 7, where most of the atoms of the starting materials are …
materials, for example, 3, 4,..., 7, where most of the atoms of the starting materials are …
Targeting cyclin-dependent kinases in human cancers: from small molecules to peptide inhibitors
M Peyressatre, C Prével, M Pellerano, MC Morris - Cancers, 2015 - mdpi.com
Cyclin-dependent kinases (CDK/Cyclins) form a family of heterodimeric kinases that play
central roles in regulation of cell cycle progression, transcription and other major biological …
central roles in regulation of cell cycle progression, transcription and other major biological …
Marine natural products
Covering: 2007. Previous review: Nat. Prod. Rep., 2008, 25, 35This review covers the
literature published in 2007 for marine natural products, with 948 citations (627 for the …
literature published in 2007 for marine natural products, with 948 citations (627 for the …
CDK9 inhibitors in acute myeloid leukemia
S Boffo, A Damato, L Alfano, A Giordano - Journal of Experimental & …, 2018 - Springer
Current treatment for acute myeloid leukemia (AML) is less than optimal, but increased
understanding of disease pathobiology and genomics has led to clinical investigation of …
understanding of disease pathobiology and genomics has led to clinical investigation of …
Variolins and related alkaloids
The phosphorylation of proteins on serine, threonine, and tyrosine residues by the 518
protein kinases encoded in the human genome constitutes one of the major mechanisms …
protein kinases encoded in the human genome constitutes one of the major mechanisms …
Cyclin-dependent kinase 9: a key transcriptional regulator and potential drug target in oncology, virology and cardiology
S Wang, PM Fischer - Trends in pharmacological sciences, 2008 - cell.com
Unlike other CDKs, CDK9 does not regulate the cell cycle but promotes RNA synthesis in
genetic programmes for cell growth, differentiation and viral pathogenesis. It is becoming …
genetic programmes for cell growth, differentiation and viral pathogenesis. It is becoming …
Recent developments in the biology and medicinal chemistry of CDK9 inhibitors: an update
T Wu, Z Qin, Y Tian, J Wang, C Xu, Z Li… - Journal of medicinal …, 2020 - ACS Publications
Cyclin-dependent kinase 9 (CDK9), which regulates transcriptional elongation, is an
attractive therapeutic target for many cancers, especially for cancers driven by transcriptional …
attractive therapeutic target for many cancers, especially for cancers driven by transcriptional …
Cyclin dependent kinase 9 inhibitors for cancer therapy: miniperspective
YA Sonawane, MA Taylor, JV Napoleon… - Journal of medicinal …, 2016 - ACS Publications
Cyclin dependent kinase (CDK) inhibitors have been the topic of intense research for nearly
2 decades due to their widely varied and critical functions within the cell. Recently CDK9 has …
2 decades due to their widely varied and critical functions within the cell. Recently CDK9 has …
[HTML][HTML] An insight into the emerging role of cyclin-dependent kinase inhibitors as potential therapeutic agents for the treatment of advanced cancers
Cancer denotes a pathological manifestation that is characterized by hyperproliferation of
cells. It has anticipated that a better understanding of disease pathogenesis and the role of …
cells. It has anticipated that a better understanding of disease pathogenesis and the role of …